Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
45 participants
INTERVENTIONAL
2020-08-07
2021-04-26
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Gentamicin Bladder Instillations to Prevent Urinary Tract Infections in Patients With Spinal Cord Injury
NCT03503513
Efficacy of the Act of Urination to Relief the Pain During Flexible Cystoscopy Procedure.
NCT05207969
Heating Pad for in Office Cystoscopy and Urodynamic Testing
NCT05981794
Intranasal Fentanyl as an Analgesic for Cystoscopic Procedures
NCT01708122
Low Energy Shock Wave for the Treatment of Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS)
NCT03619486
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Standard Cystoscopy
Patients will undergo a standard of care cystoscopy
Standard Cystoscopy
Patient will undergo standard cystoscopy
PTNS and Cystoscopy
Patients will undergo PTNS while undergoing cystoscopy
Percutaneous Tibial Nerve Stimulation (PTNS)
PTNS is neuromodulation that uses electricity to stimulate the nervous system, specifically the posterior tibial nerve, and is minimally invasive.
Standard Cystoscopy
Patient will undergo standard cystoscopy
Sham PTN and Cystoscopy
Patients will undergo a sham PTNS procedure while undergoing cystoscopy
Sham Percutaneous Tibial Nerve Stimulation (PTNS)
Patients will be connected to the PTNS device but the device will remain off for the entirety of the procedure
Standard Cystoscopy
Patient will undergo standard cystoscopy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Percutaneous Tibial Nerve Stimulation (PTNS)
PTNS is neuromodulation that uses electricity to stimulate the nervous system, specifically the posterior tibial nerve, and is minimally invasive.
Sham Percutaneous Tibial Nerve Stimulation (PTNS)
Patients will be connected to the PTNS device but the device will remain off for the entirety of the procedure
Standard Cystoscopy
Patient will undergo standard cystoscopy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients undergoing routine office-based cystoscopy by a urology provider
Exclusion Criteria
* Patients undergoing cystoscopy due to concern for urologic injury
* Patients undergoing cystoscopy due to concern for prosthetic abnormality, including erosion or malposition
* Patients who perform clean intermittent catheterization
* Patients with pre-existing neurological pathology, including but not limited to multiple sclerosis, spinal cord injury, Parkinson's disease, or peripheral neuropathy of any etiology
* Patients having undergone prior non-endoscopic prostatectomy (radical prostatectomy, simple prostatectomy)
* Patients with a history of interstitial cystitis/chronic pelvic pain
* Patients who have taken an analgesic (excluding 81mg aspirin) in the past 12 hours
* Patients with a history of urethral stricture disease
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Kansas Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jeffrey Holzbeierlein
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jeffrey Holzbeierlein, MD
Role: PRINCIPAL_INVESTIGATOR
University of Kansas Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Kansas Health System
Kansas City, Kansas, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
145954
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.